MDIT Stock - Medite Cancer Diagnostics, Inc.
Unlock GoAI Insights for MDIT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Revenue | $6.81M | $9.24M | $9.89M |
| Gross Profit | $-131,000 | $3.42M | $3.63M |
| Gross Margin | -1.9% | 37.0% | 36.7% |
| Operating Income | $-6,480,000 | $-1,661,000 | $-599,000 |
| Net Income | $-6,811,000 | $-2,163,000 | $-859,000 |
| Net Margin | -100.0% | -23.4% | -8.7% |
| EPS | $-0.26 | $-0.10 | $-0.04 |
Medite Cancer Diagnostics, Inc. operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning. It also provides M630, a freezing microtome; TST44, a robotic multi-staining system; COT 20, a linear staining system; and RCM 9000, ACS 720, and TWISTER robotic coverslippers. In addition, the company develops SoftKit device for the self-collection of a sample that can be evaluated to provide an assessment of the health of the entire female genital tract. It sells its products through direct sales and distributors in the United States, China, Europe, and North Africa. The company serves histology and cytology laboratories associated with hospitals or research institutions, and independent laboratories. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida.
Visit WebsiteEarnings History & Surprises
MDITEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2018 | Nov 14, 2018 | — | $-0.01 | — | — |
Q3 2018 | Aug 10, 2018 | — | $-0.01 | — | — |
Q4 2017 | Nov 14, 2017 | — | $-0.06 | — | — |
Q3 2017 | Aug 14, 2017 | — | $-0.06 | — | — |
Q2 2017 | May 15, 2017 | — | $-0.04 | — | — |
Q4 2016 | Nov 15, 2016 | — | $-0.02 | — | — |
Q3 2016 | Aug 25, 2016 | — | $-0.01 | — | — |
Q2 2016 | Apr 12, 2016 | — | $-0.03 | — | — |
Q4 2015 | Nov 13, 2015 | — | — | — | — |
Q3 2015 | Aug 13, 2015 | — | — | — | — |
Latest News
Frequently Asked Questions about MDIT
What is MDIT's current stock price?
What is the analyst price target for MDIT?
What sector is Medite Cancer Diagnostics, Inc. in?
What is MDIT's market cap?
Does MDIT pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MDIT for comparison